6-Minute walk test for prediction of heart failure in stable outpatients
Background and Objective: Heart failure (HF) is becoming an increasingly serious public health issue. The six-minute walk test (6-MWT) is a useful tool for determining the prognosis of HF patients. Due to a lack of research on their predictive relevance in 6-MWT, the goal of the study was to see if 6-MWT was indeed beneficial as a predictive indicator of death in patients with mild-to-moderate congestive heart failure.
Methods: Secondary data was employed in this investigation. The 6-MWT was used to divide the walking lengths of 45 individuals with HF into two performance levels: Group I ≤300 m and Group II >300 m. All of the patients had left ventricular systolic dysfunction (ejection fraction, 38.23 ±7.348) and were in stable New York Heart Association functional classes II (91.1%) and III (6.7%) heart failure, respectively. Data were analyzed using SPSS. log-rank test was used for comparison of the 2 curves.
Results: The current findings reported that the risk of death was significantly higher in patients whose 6MWT distance (6MWTD) was ≤300m, as compared to patients whose 6MWTD was >300m (Cox regression model). The fatality rate was significantly lower in patients with a 6MWTD of ≤300 m, compared to patients with a 6MWTD of >300 m.
Conclusions: According to the findings, a 6MWTD of less than 300 m is useless as a predictive indication of death in patients with mild to moderate congestive HF.
The articles in AJMAS are published in Open Access mode, and they are available freely and immediately worldwide. The AJMAS site and its metadata are licensed under CC BY 4.0